Stenocare AS (STENO) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.010x

Based on the latest financial reports, Stenocare AS (STENO) has a cash flow conversion efficiency ratio of 0.010x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Dkr85.84K ≈ $13.43K USD) by net assets (Dkr9.01 Million ≈ $1.41 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Stenocare AS to measure how many days the company can operate on defensive assets alone.

Stenocare AS - Cash Flow Conversion Efficiency Trend (2018–2025)

This chart illustrates how Stenocare AS's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Stenocare AS Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Stenocare AS ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Carver Bancorp Inc NASDAQ:CARV	-0.059x
Hanil Vacuum Co. Ltd KQ:123840	-0.052x
TruCap Finance Limited NSE:TRU	1.175x
Bon Natural Life Ltd NASDAQ:BON	0.076x
Miraculum SA WAR:MIR	0.012x
Palred Technologies Limited NSE:PALREDTEC	0.041x
Entero Therapeutics, Inc. NASDAQ:GRDX	-0.010x
Delta Manufacturing Limited NSE:DELTAMAGNT	-0.091x

Annual Cash Flow Conversion Efficiency for Stenocare AS (2018–2025)

The table below shows the annual cash flow conversion efficiency of Stenocare AS from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see Stenocare AS stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Dkr9.47 Million ≈ $1.48 Million	Dkr-7.21 Million ≈ $-1.13 Million	-0.762x	-137.05%
2024-12-31	Dkr-3.47 Million ≈ $-543.48K	Dkr-7.14 Million ≈ $-1.12 Million	2.056x	+628.68%
2023-12-31	Dkr25.82 Million ≈ $4.04 Million	Dkr-10.04 Million ≈ $-1.57 Million	-0.389x	+37.55%
2022-12-31	Dkr24.14 Million ≈ $3.78 Million	Dkr-15.03 Million ≈ $-2.35 Million	-0.623x	-87.79%
2021-12-31	Dkr40.24 Million ≈ $6.30 Million	Dkr-13.34 Million ≈ $-2.09 Million	-0.332x	-37.22%
2020-12-31	Dkr52.57 Million ≈ $8.23 Million	Dkr-12.70 Million ≈ $-1.99 Million	-0.242x	-27.96%
2019-12-31	Dkr13.47 Million ≈ $2.11 Million	Dkr-2.54 Million ≈ $-398.12K	-0.189x	+30.65%
2018-12-31	Dkr20.47 Million ≈ $3.20 Million	Dkr-5.57 Million ≈ $-872.16K	-0.272x	--

About Stenocare AS

CO:STENO Denmark Drug Manufacturers - Specialty & Generic

Market Cap

$7.40 Million

Dkr47.30 Million DKK

Market Cap Rank

#27723 Global

#129 in Denmark

Share Price

Dkr1.10

Change (1 day)

+4.78%

52-Week Range

Dkr0.46 - Dkr2.72

All Time High

Dkr37.18